New single-cell studies reveal distinct immune aging trajectories in women and men, with implications for personalized vaccines, autoimmune monitoring, and cancer screening. The immune system ages dif...
Recent breakthroughs in epigenetic clocks, particularly DunedinPACE, enhance mortality prediction accuracy by up to 20%, validated by studies like BASE-II, and drive innovations in personalized medici...
Exploring recent advances in senolytic and senomorphic therapies, including dasatinib-quercetin and immune-based approaches, to combat age-related diseases like Alzheimer’s and sarcopenia. New t...
Recent research identifies specific senescent cell types linked to diabetes and hypertension, enabling personalized therapies and AI-driven predictive health tools for aging populations. New studies m...
INSITE technology uses ultrasound-guided delivery of hepatocytes in hydrogel microspheres to create vascularizable scaffolds, potentially reducing the need for liver transplants and addressing donor s...
A July 2024 study in ‘Nature Aging’ validates p-tau217 blood biomarkers for forecasting Alzheimer’s symptoms within 3-4 years, enhancing early intervention and personalized medicine....
New evidence supports menopausal hormone therapy for reducing mortality and enhancing healthspan, with updated guidelines emphasizing personalized approaches based on recent studies and expert insight...
DeepRare, a multi-agent AI system, achieves 10% higher accuracy than expert physicians in diagnosing rare diseases, potentially reducing diagnostic delays and transforming clinical practice with trans...
New research identifies IRF7 as a critical driver of unstable atherosclerotic plaques, offering a potential therapeutic target to reduce cardiovascular events through innovative clinical trials and te...
Recent studies reveal CAR-T cells with lecanemab antibodies reduce amyloid plaques in mice, highlighting a shift towards personalized cell-based therapies for Alzheimer’s treatment. New research...
